Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (181-190 of 318) with videos related to

Pageof 32
Sort By:
Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.
NPJ Digital Medicine|April 25, 2025
Machine learning-based forecasting of daily acute ischemic stroke admissions using weather dataNandhini Santhanam, Hee E Kim, David Rügamer, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)Riccardo Pecori, Beatrice Casati, Rona Merdler-Rabinowicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2017
Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan CatabolismLars-Oliver Tykocinski, Anna M Lauffer, Antonia Bohnen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2014
A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastomaWolfgang Wick, Harald Fricke, Klaus Junge, et al.
Molecular & Cellular Proteomics : MCP|August 7, 2024
optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input MaterialMogjiborahman Salek, Jonas D Förster, Jonas P Becker, et al.
Neuro-Oncology|October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglioMartha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
Cell|April 14, 2023
Cancer neuroscience: State of the field, emerging directionsFrank Winkler, Humsa S Venkatesh, Moran Amit, et al.
Pageof 32

Showing results (181-190 of 318) with videos related to

Sort By:
Pageof 32
Journal of Neurochemistry|July 1, 2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?Dieter Lemke, Markus Weiler, Jonas Blaes, et al.
NPJ Digital Medicine|April 25, 2025
Machine learning-based forecasting of daily acute ischemic stroke admissions using weather dataNandhini Santhanam, Hee E Kim, David Rügamer, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)Riccardo Pecori, Beatrice Casati, Rona Merdler-Rabinowicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2017
Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan CatabolismLars-Oliver Tykocinski, Anna M Lauffer, Antonia Bohnen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2014
A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastomaWolfgang Wick, Harald Fricke, Klaus Junge, et al.
Molecular & Cellular Proteomics : MCP|August 7, 2024
optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input MaterialMogjiborahman Salek, Jonas D Förster, Jonas P Becker, et al.
Neuro-Oncology|October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglioMartha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
Cell|April 14, 2023
Cancer neuroscience: State of the field, emerging directionsFrank Winkler, Humsa S Venkatesh, Moran Amit, et al.
Pageof 32